GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » InnoCan Pharma Corp (XCNQ:INNO) » Definitions » Forward Dividend Yield %

InnoCan Pharma (XCNQ:INNO) Forward Dividend Yield % : 0.00% (As of May. 13, 2024)


View and export this data going back to 2019. Start your Free Trial

What is InnoCan Pharma Forward Dividend Yield %?

As of today (2024-05-13), the Forward Annual Dividend Yield of InnoCan Pharma is 0.00%.

As of today (2024-05-13), the Trailing Annual Dividend Yield of InnoCan Pharma is 0.00%.

XCNQ:INNO's Forward Dividend Yield % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.855
* Ranked among companies with meaningful Forward Dividend Yield % only.

InnoCan Pharma's Dividends per Share for the three months ended in Dec. 2023 was C$0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of InnoCan Pharma's Forward Dividend Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, InnoCan Pharma's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InnoCan Pharma's Forward Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, InnoCan Pharma's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where InnoCan Pharma's Forward Dividend Yield % falls into.



InnoCan Pharma Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


InnoCan Pharma  (XCNQ:INNO) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


InnoCan Pharma Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of InnoCan Pharma's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


InnoCan Pharma (XCNQ:INNO) Business Description

Traded in Other Exchanges
Address
1015, 926 - 5 Avenue SW, Calgary, AB, CAN, T2P 0N7
InnoCan Pharma Corp is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals. Geographically, it derives a majority of its revenue from the United States.

InnoCan Pharma (XCNQ:INNO) Headlines

From GuruFocus

President of Innocap, Inc. is in Singapore

By Marketwired Marketwired 05-03-2018

President of Innocap, Inc. is in Singapore

By GlobeNewswire GlobeNewswire 05-03-2018

Innocap, Inc. Year End Message To Shareholders

By PRNewswire PRNewswire 12-14-2020

Innocap, Inc.'s Current Activities

By Marketwired Marketwired 05-24-2018